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The body requires the generation of regulatory T (Treg) cells to preserve its integrity. Each microenvironment
is controlled by a specific set of regulatory elements that have to be finefrly and constantly tuned to maintain
local homeostasis. These environments could be site specific, such as the gut environment, or induced by
chronic exposure to microbes or tumors. Various populations of dendritic cells (DCs) are central to the
orchestration of this control. In this review, we will discuss some new findings associating DCs from defined
compartments with the induction of antigen-specific Treg cells.Introduction
Several types of CD4+ regulatory T (Treg) cells have been de-
scribed on the basis of their origin, generation, and mechanism
of action with two main origins identified: thymically derived
Foxp3+ Treg cells and inducible Treg cells, which are comprised
of interleukin-10 (IL-10)-producing T regulatory 1 (Tr1) cells (Ron-
carolo et al., 2006), transforming growth factor-b (TGF-b)-produc-
ing T helper (Th) cells (Faria and Weiner, 2005), and inducible
Foxp3+ T cells (Chen et al., 2003). Both types of regulatory T cell,
by virtue of their capacity to control the intensity of effector re-
sponses,playamajor role in thecontrol ofperipheral homeostasis.
Although a large number of mechanisms, including natural
Foxp3+ Treg cell, contribute to themaintenance of peripheral tol-
erance, in defined situations or specific sites, the body requires
the generation of Treg cells to preserve its integrity. Each micro-
environment is controlled by a specific set of regulatory elements
that have to be finely and constantly tuned to maintain local ho-
meostasis. These environments could be site specific, such as
the gut environment, or induced by chronic exposure to mi-
crobes or tumor (Figure 1). Dendritic cells (DCs) are central to
the orchestration of this control (Figure 2). Under steady-state
conditions, the default pathway of resident immature DCs is
the induction of Treg cells. In the context of disturbance of the
immune system, DCs manipulated by microbes or the tumor
environment can acquire the capacity to induce new populations
of antigen-specific Treg cells. These induced Treg cells are ex-
pected to have the antigen specificities and survival requirement
appropriate for targeted control of immune responses.
Induction of Foxp3+ Treg Cells by DCs
Although a role for Foxp3+ Treg cells in the maintenance of im-
mune tolerance has been demonstrated in both humans and
mice, the origin of these cells is still not completely understood.
Early neonatal thymectomy experiments in mice strongly sug-
gested that Treg cells are generated in the thymus. Studies
with Foxp3 reporter mice (Fontenot et al., 2005a) and transgenic
mice that express foreign antigens in thymic tissue (Bensinger
et al., 2001; Jordan et al., 2001) have also traced the develop-
ment of Foxp3+ cells to the thymus. Aside from evidence that
natural Foxp3+ Treg cells arise and mature in the thymus, there
is mounting evidence that Foxp3+ Treg cells can develop extra-362 Immunity 29, September 19, 2008 ª2008 Elsevier Inc.thymically under certain conditions. Both murine (Bettelli et al.,
2006; Chen et al., 2003) and human (Fantini et al., 2004) naive
T cells have been shown to express Foxp3 and acquire suppres-
sive activity in vitro after T cell receptor (TCR) stimulation in the
presence of TGF-b. In vivo, delivery of subimmunogenic doses
of antigen (Kretschmer et al., 2005) as well as endogenous
expression of foreign antigen in a lymphopenic environment
(Knoechel et al., 2005) can also induce peripheral Foxp3+ Treg
cell development.
Despite a growing body of literature documenting a potential
role for these converted cells in the control of autoimmune or in-
flammatory diseases (Curotto de Lafaille et al., 2008), the nature
of the antigen-presenting cells (APCs) involved in this conversion
process remains poorly understood. Several reports support the
idea that immature DCs may be more efficient at inducing
Foxp3+ Treg cell development in the presence of TGF-b than ac-
tivated DCs. For example, targeting of antigens to immature DCs
via the regulatory receptor DEC205 can favor the induction of
Foxp3+ T cell development de novo (Knoechel et al., 2005). Al-
though virtually all APCs at steady-state conditions may have
the capacity to induce antigen-specific Treg cells, DCs appear
to be more efficient at this process than other APCs (Yamazaki
et al., 2007). Thus, spleen DCs are more potent than DC-de-
pleted APCs for the induction of Treg cells and require lower
doses of peptide antigen (Yamazaki et al., 2007). In the absence
of exogenous IL-2, endogenous IL-2 production by T cells favor-
ing Treg cell conversion can be efficiently triggered by DCs
expressing CD80 and CD86 but not by other APCs (Yamazaki
et al., 2007). However, another study has proposed that B cells
are more efficient at inducing Foxp3+ Treg cells than splenic
DCs in the presence of TGF-b (Benson et al., 2007). This discrep-
ancy is likely to be associated with the level of activation of the
APCs in these different settings.
Several reports suggest that the status of activation of DCs as
well as inflammatory mediators modulates the capacity of these
cells to induce Treg cells de novo (Bettelli et al., 2006; Korn et al.,
2007; Nurieva et al., 2007; Stumhofer et al., 2006; Veldhoen et al.,
2006; Zhou et al., 2007). For example, IL-6 and TGF-b in tandem
can direct the production of IL-17-secreting T cells (Th17 cells)
over Treg cells (Bettelli et al., 2006; Veldhoen et al., 2006), and
Th1 and Th2 cell effector cytokines have an antagonistic effect
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ReviewFigure 1. Induction of Regulatory T Cells in Defined Microenvironnements
In intestine lamina propria, several subsets of DCs reside and are in close contact with lumen antigen, like gut flora and food-derived antigens. To maintain local
homeostasis, these DCs can induce the differentiation of Tr1 cells, TGF-b-secreting T cells, and Foxp3 Treg cells. In particular, CD103+ DCs can induce the neo-
conversion of Foxp3+ Treg cells via their capacity to release TGF-b and retinoic acid. These de novo-induced Foxp3+ Treg cells express the gut-homing receptors
CC-chemokine receptor 9 (CCR9) and a4b7-integrin. In the tumor microenvironment, tumor cells produce suppressive factors that license DCs, myeloid-derived
suppressor cells, or tumor-associated macrophages to induce Treg cells. The consequence of this induction is enhanced local immune suppression. In chronic
infections, Treg cells can be induced. The consequence of this induction is maintenance of microbial persistence and limitation of collateral tissue damages.on Treg cell conversion (Wei et al., 2007). Through the use of an
APC-free system in vitro, it has been suggested that strong cos-
timulation provided by extensive CD28 signaling can inhibit
Foxp3 induction (Benson et al., 2007). In vivo, efficient induction
of Foxp3+ Treg cells is also abolished in the presence of strong
costimulation (Kretschmer et al., 2005). DCs deficient in CD80
and CD86 induce higher expression of Foxp3 on naive T cells
than control DCs (Benson et al., 2007). Furthermore, when ex
vivo spleen DCs were activated with an agonist anti-CD40 or
lipopolysaccharide, induction of Foxp3+ Treg cells was impaired
(Wang et al., 2008). Thus, activated DCs are poor inducers of
Foxp3+ Treg cells in favor of the induction of effector responses.
This is in contrast with the observation that activated DCs are
more efficient at inducing the proliferation of natural Treg cells
than immature DCs (Tarbell et al., 2004; Yamazaki et al., 2003).
This could suggest that in some defined situations, Treg cells
could play a sequential and complementary role. For instance,
the endogenous population may preferentially control highly
inflammatory settings, whereas converted Treg cells may play
a more important role during the downstream of the inflamma-
tory process or in situation of chronic infections.
The demonstration that some DCs subsets from lymphoid tis-
sues could be more efficient at inducing Treg cells than others
came from a study showing that CD8+ DCs induce higher
conversion than other spleen DC subsets in the presence of
TGF-b (Wang et al., 2008). Several molecules contribute to the
induction of Foxp3+ Treg cell development. For instance, the
B7-CTLA-4 axis is important to favor the induction of these cells
(Belghith et al., 2003; Liang et al., 2005; Zheng et al., 2006). A rolefor PD-L1 expressed by DCs in the induction of Treg cells has
been recently reported (Wang et al., 2008), adding another po-
tential role of this molecule in the control of peripheral tolerance
(Latchman et al., 2004).
Previous work demonstrates that CD3 antibody treatment
transiently depletes large numbers of T cells and subsequently
induces long-term immune tolerance (Belghith et al., 2003). A re-
cent study provides evidence that the mechanism underlying
this regulatory effect is an enhanced production of TGF-b by
macrophages and immature DCs after engulfment of apoptotic
T cells (Perruche et al., 2008). This increase in TGF-b induces
the development of Foxp3+ Treg cells and contributes to immune
tolerance (Perruche et al., 2008). Clearance of apoptotic bodies
has been shown to lead to the development of Treg cells (Lacy-
Hulbert et al., 2007). The relative contribution of this pathway
in the constitutive generation of Treg cells at sites with a high
amount of remodeling (e.g., gut or uterus) remains to be
addressed.
Role of Tissue-Specific DCs in the Induction
of Treg Cells
No other tissue is subjected to more antigenic pressure than the
gut. For instance, the adult human intestine contains up to 1014
microorganisms (Backhed et al., 2005). It is therefore a highly
regulated immunologic site that must generate both tolerogenic
and immunogenic responses. On one hand, immune reactivity
against nonpathogenic gut elements is not only wasteful but
also dangerous to the host and is known to lead to severe tissue
damages (e.g., inflammatory bowel disease). On the other hand,Immunity 29, September 19, 2008 ª2008 Elsevier Inc. 363
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host against invasive pathogens. Different subsets of Treg cells
have been shown to be instrumental in the maintenance of this
complex homeostasis. Additionally, several subsets of DCs
with regulatory properties have been describedwith the capacity
to induce IL-10 secretion from T cells or induce oral tolerance at
steady-state conditions (Chirdo et al., 2005; Coombes and Pow-
rie, 2008; Iwasaki and Kelsall, 2001; Mowat, 2003). Some of
these features may have been influenced by conditioning signals
received from noninflammatory cytokines constitutively pro-
duced by the intestinal epithelia. These cytokines include TGF-b
and the Th2 cell response driving thymic stromal lymphopoietin
(Barnard et al., 1993; Coombes and Powrie, 2008; Rimoldi et al.,
2005).
It has recently been demonstrated that the gut-associated
lymphoid tissue is a preferential site for the peripheral induction
of Foxp3+ Treg cells (Coombes et al., 2007; Mucida et al., 2005,
2007; Sun et al., 2007). A role for local DCs in this conversion pro-
cess is supported by the observation that DCs from the lamina
propria of the small intestine and from the mesenteric lymph
node (MLN) are noticeably better than splenic DCs at inducing
the expression of Foxp3 in naive T cells in the presence of exog-
enous TGF-b (Coombes et al., 2007; Sun et al., 2007). Similarly,
Figure 2. Various Populations of DCs Can Induce Antigen-Specific
Treg Cells
Steady-state immature DCs can induce Treg cells. Defined subsets of gut DCs
such as CD11cloCD45RBhi or CD103+ can induce new populations of Treg
cells. In some cases, DCs conditioned by Foxp3+ Treg cells, pathogen-derived
molecules (e.g., filamentous haemagglutinin [FHA], adenylate cyclase toxin
[CyaA]) or exogenous signals [e.g., TNF-a, adenosine, prostaglandin D(2), or
immunosuppressive drugs like Vitamin D3 metabolite 1a,25-(OH)2D3, cortico-
steroids] can induce new population of Treg cells. Various populations of Treg
cells are induced to control local homeostasis. Foxp3+ Treg cells can control
local responses via mechanisms including the production of IL-10, TGF-b,
cAMP, Granzyme B, adenosine, IL-35, or CTLA-4 (Vignali, 2008). Tr1 cells
can control immune responses via their capacity to release TGF-b and IL-
10. TGF-b producing Th cells can control local responses via their production
of TGF-b.364 Immunity 29, September 19, 2008 ª2008 Elsevier Inc.lamina propria macrophages can efficiently induce Foxp3+
T cells (Denning et al., 2007). In particular, DCs expressing
CD103+ in these two compartments can induce Foxp3+ T cells
in the absence of any exogenous factors (Coombes et al.,
2007; Sun et al., 2007). This conversion process was associated
with their capacity to release bioactive TGF-b, which could be
linked with their capacity to activate latent TGF-b (Coombes
et al., 2007). This hypothesis is supported by the observation
that DCs lacking the TGF-b-activating integrin avb8 or av fail to
induce Foxp3+ Treg cells in vitro (Lacy-Hulbert et al., 2007; Travis
et al., 2007). Furthermore, mice in which myeloid cells do not ex-
press av or DCs that do not express avb8 have reduced colonic
Foxp3+ Treg cells and develop colitis (Lacy-Hulbert et al., 2007;
Travis et al., 2007). Loss of v-integrin expression bymyeloid cells
led to the development of intestinal inflammation, probably
through the combined effects of a failure to remove apoptotic
cells and a loss of TGF activation (Lacy-Hulbert et al., 2007).
Although DCs derived from the lamina propria and MLN can
efficiently induce Treg cells, the exact sites in which these events
take place remains unclear. We cannot exclude that Treg cell
conversion may occur in the lamina propria, because a small
but sizeable population of naive cells can be found in this tissue.
However, early after oral feeding with antigen, most of the con-
verted cells can be found in the MLN preceding their accumula-
tion in the lamina propria (Y.B., unpublished data). Gut DCs con-
stitutively transport apoptotic epithelial cells to the MLN (Huang
et al., 2000). Recent evidence also suggest that the majority of
CD103+ DCs represent a tissue-derived migratory population
that plays an important role in presenting orally derived soluble
antigen to T cells (Jaensson et al., 2008). Thus, as predicted by
previous studies showing a central role for the MLN in the acqui-
sition of oral tolerance (Spahn et al., 2002), most of the conver-
sion may occur in this compartment in response to tissue-
migrating CD103+ DCs. A likely hypothesis would be that these
gut-converted Treg cells could become part of the peripheral
Treg cell pool. So, over time, the gut flora, oral pathogens, or
food may have an important role in shaping the repertoire of
peripheral Foxp3+ Treg cells. The relative contribution of these
converted Treg cells to peripheral tolerance and the outcome
of infections, as well as how pathogens can utilize or interfere
with this pathway to favor their own survival, remains to be ad-
dressed. Currently, in absence of definitive markers to distin-
guish endogenous versus converted Foxp3+ Treg cells, these
questions will remain difficult to answer.
Role of DC-Derived Products in Imprinting Homing
and Regulatory Properties
Gut DCs also have an important role in dictating the homing po-
tential of lymphocytes. DCs isolated from the Peyer’s patches,
small-intestinal lamina propria, and MLNs promote the expres-
sion of the gut-homing receptors a4b7-integrin and CCR9 by
CD4+ and CD8+ T cells (Johansson-Lindbom et al., 2003,
2005; Lo´pez-Bravo and Ardavı´n, 2008, in this issue of Immunity;
Mora et al., 2003; Stagg et al., 2002). The molecule CCR9 binds
to CCL25 produced by epithelial cells of the small intestine, and
a4b7-integrin binds to mucosal vascular addressin cell-adhesion
molecule 1 (MADCAM1), which is expressed by the vascular en-
dothelium of the gastrointestinal tract. It is also becoming clear
that nutrient status can impact an individual’s susceptibility to
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and, in particular, its transcriptionally active metabolite, retinoic
acid (RA), prolonged insufficiency not only disrupts the integrity
of the intestinal epithelial barrier but also prevents the proper
deployment of effector lymphocytes into the gut-associated lym-
phoid tissue (GALT) after priming. Indeed, the capacity of GALT
DCs to imprint gut-homing receptors to lymphocytes is associ-
ated with their capacity to release retinoic acid (Iwata et al.,
2004; Mora et al., 2006; Ziegler et al., 2003). More recently, it
was demonstrated that RA and cytokines produced by DCs in
the Peyer’s Patches synergized to promote IgA secretion by
gut-activated B cells (Mora et al., 2006). Importantly, the addition
of RA to naturally occurring Treg cells in vitro can promote their
expression of gut tropism receptors and subsequently favor their
migration to the GALT (Siewert et al., 2007). Another effect of RA
on the immune regulation of the gastrointestinal (GI) tract is
associatedwith its capacity toenhance theTGF-b-mediatedgen-
eration of Foxp3+ Tregcells fromnaiveT cells bygutDCs (Benson
et al., 2007;Coombeset al., 2007;Denninget al., 2007;Eliaset al.,
2008; Kang et al., 2007; Mucida et al., 2007; Schambach et al.,
2007;Sunet al., 2007) (Figure 1). The inductionof Foxp3observed
in the presence of small-intestinal lamina propria DCs and
CD103+ MLN DCs can be inhibited by a retinoic-acid receptor
(RAR) antagonist (Coombes et al., 2007; Sun et al., 2007). Con-
versely, incubation of splenic or CD103 MLN DCs with both
TGF-bandRAenhanced their capacity to induceFoxp3Tregcells
(Coombes et al., 2007; Mucida et al., 2007; Sun et al., 2007). RA
produced by intestinal macrophages can also synergize with
TGF-b to induce Foxp3+ Treg cells (Denning et al., 2007). Impor-
tantly, RAcan induce theconversionof naiveCD4+T cells purified
from human cord blood into Foxp3+ Treg cells (Kang et al., 2007).
Reciprocally, RA can inhibit the generation of Th17 cells (Elias
et al., 2008; Kang et al., 2007; Mucida et al., 2007; Schambach
et al., 2007), suggesting that RA may play an important role in
maintaining the balance between effector and regulatory popula-
tions in the GI tract. The mechanism by which RA produced by
DCscan enhance the capacity of TGF-b to induceFoxp3on naive
T cells remains unclear but is likely due to a conjunction of effects
on both T cells and DCs. One possible role of RA would be via its
capacity to enhance TGF-b signaling, e.g., RA can increase the
expression of TGF-b receptor subunit (Balmer and Blomhoff,
2002). Another possibility could be associated with the capacity
of RA to suppress effector cytokines known to suppress the in-
ductionof Foxp3byTcells (Cantornaet al., 1996;Wei et al., 2007).
In addition to the gut, other compartments could be involved in
the generation of Foxp3+ T cells. For instance, a recent report
demonstrated that liver plasmacytoid DCs can contribute to
the acquisition of tolerance against oral antigens (Goubier
et al., 2008, in this issue). Of importance, the liver and in partic-
ular Ito cells can store up to 80% of total body retinol (Geerts,
2004). How liver DCs can acquire retinol form these cells and
convert it to RA remains to be addressed.
Although the capacity of GALTDCs ormacrophages to imprint
gut-homing receptors and induce Foxp3+ Treg cells is associ-
ated with their capacity to release RA, it remains unclear whether
these cells are the main producer of this metabolite in the gut.
Synthesis of RA from stored or dietary retinol depends on the ex-
pression of the appropriate enzymes, which can be expressed
directly by GALT DCs. DCs from Peyer’s patches and MLNs ex-press Aldh1a1 and Aldh1a2, respectively (Coombes et al., 2007;
Iwata et al., 2004). DCs from the lamina propria express a large
array of this family of enzymes, such as ADH1, ADH4, ADH5,
Adh1a1, Adh1a2, and Adh1a3 (Y.B., unpublished data). Sup-
porting the idea of a role for these cells as producers of RA,
Peyer’s patch and MLN DCs can directly convert retinol to RA
in culture (Iwata et al., 2004). However other cells, including
epithelial cells, can express enzymes associated with vitamin A
metabolism (Saurer et al., 2007), suggesting that DCs may also
acquire RA from other sources and store it. A recent study dem-
onstrates that monocyte-derived DCs pretreated with RA can
acquire several attributes characteristic of mucosal DCs, such
as secretion of TGF-b and IL-6 and the capacity to augment mu-
cosal-homing receptor expression and IgA production. In this
particular study, these gut-derived features acquired by DCs
were associated with the capacity of DCs to become carriers
and not producers of RA (Saurer et al., 2007). The precise factors
that govern the activation of some of these enzymes and how in-
flammation or infections modify the metabolism of vitamin A
remain to be explored. Another important question would be to
understand the timing necessary for DCs migrating in the
GALT to acquired RA from epithelial cells and how these pro-
cesses can be modified during inflammatory responses. How
RA contributes to oral tolerance and at the same time protective
immunity in the GI tract also remains to be addressed. One pos-
sibility would be that RA could favor the induction of Treg cells in
the absence of secondary signals but enhances effector re-
sponse after exposure to inflammatory mediators. Indeed,
lamina propria DCs stimulated with flagellin can induce the dif-
ferentiation of Th17 cells in an RA-dependent manner, suggest-
ing that at physiological doses RA does not inhibit but rather pro-
motes this pathway (Vijay-Kumar et al., 2008). This observation is
consistent with the fact that the gut enriched in RA is home to
a large number of IL-17-producing T cells at steady-state condi-
tion (Ivanov et al., 2006). After exposure to CpG, lamina propria
dendritic cells can prevent the induction of Treg cells while in-
ducing effector T cells expressing a high amount of RA-depen-
dent gut-homing receptors (Y.B., unpublished data).
The shared feature by local mediators to imprint homing and
regulatory properties is also observed in another defined micro-
environment. Vitamin D3 is generated as an inactive form in the
skin in response to sunlight and is converted to the active
form, 1,25-dihydroxyvitamin D3 [1,25(OH)2D3], by an enzymatic
cascade involving 25-hydroxylases and 1-hydroxylase. The D vi-
tamins have many effects on immune cells. It has been shown
that 1,25(OH)2D3 can inhibit the differentiation and maturation
of DCs (Griffin et al., 2000; Penna and Adorini, 2000; Piemonti
et al., 2000), leading to decreased IL-12 and enhanced IL-10 pro-
duction and decreased T cell activation. Several experimental
evidences support the regulatory function of vitamin D. Mouse
models revealed that that 1,25(OH)2D3 can inhibit several auto-
immune-disease models in mice (Cantorna and Mahon, 2005).
Vitamin D3 in combination with dexamethasone can also favor
the induction of cells able to produce IL-10with strong regulatory
properties (O’Garra et al., 2008). Vitamin D3 was also shown to
confer T cell tropism in the skin (Sigmundsdottir et al., 2007).
CCL27 is a skin-specific chemokine ligand expressed by kerati-
nocytes in the epidermis, and the expression of its receptor
CCR10 allows T cells to migrate toward this chemokine. VitaminImmunity 29, September 19, 2008 ª2008 Elsevier Inc. 365
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vitamin D3 suppressed the expression of the gut-homing recep-
tors a4b7-integrin and CCR9 by T cells. Gene-expression analy-
sis of skin DCs showed that they express both 25-hydroxylase
and 1-hydroxylase, produce active vitamin D3, and induce
CCR10 expression on T cells (Sigmundsdottir et al., 2007).
Vitamin D can also enhance the suppressive capacity of
Foxp3+ T cells from regional lymph node when delivered topi-
cally (Gorman et al., 2007).
Defined microenvironments may have evolved self-containing
strategies in which local mediators can imprint homing proper-
ties while at the same time favoring the induction or function of
Treg cells. Site-specific cells or factors such as neurons or hor-
mones can also favor the induction of Foxp3+ Treg cells (Liu
et al., 2006; Tai et al., 2008). It is therefore tempting to speculate
that a link between homing and regulatory function induction
may represent a more general mechanism. Such strategy could
allow the constant generation and migration of Treg cells to de-
fined compartments. These Treg cells are expected to have the
prerequisite antigen specificities (e.g., flora antigens), status of
activation, and survival requirement, allowing them to regulate
a defined microenvironment.
Treg Cells Induced by Microbe-Manipulated DCs
In order to sustain their transmission and/or reproduction, a large
number of microbes have to establish long-term interactions
with their host. During this coexistence, the microbe must avoid
elimination by the host immune response and sustain its life
cycle, while at the same time delaying or preventing host de-
struction. Microbe-mediated modulation of innate and acquired
immune responses of the persistently infected host has to meet
these requirements and restore a homeostatic environment. Fail-
ure to establish or maintain homeostatic conditions usually
causes disease. This is clearly the case of microflora that invade
our gut or our skin, as well as for pathogenic microbes that
establish chronic infections. All persistent microbes obey the
same principle: the immune system constitutes their ecological
niche, and they have coevolved with their host to learn how to
manipulate APC function in order to dictate an immune response
appropriate to insure their survival. For instance, microbes have
been shown to induce a large array of regulatory cells to insure
their own survival (Belkaid, 2007). Surviving an infection requires
the generation of a controlled immune response in the host that
recognizes and controls the invading pathogenwhile limiting col-
lateral damage to self-tissues that may result from an exuberant
immune response. This implies that induction of Treg cells also
arises as a result of the host response to the infectious process
in a bid to maintain or restore a homeostatic environment and/or
that it can be actively induced by the pathogen to promote path-
ogen survival (Belkaid, 2007) (Figure 1).
The role of IL-10 as an immunoregulatory cytokine in infection
has beenmainly documented in the context of chronic infections
(Moore et al., 2001). IL-10 can inhibit the immune responses (by
both Th1 cells and Th2 cells) to many pathogens in experimental
models (Gazzinelli et al., 1992; Hoffmann et al., 2000; Li et al.,
1999) and in human infectious diseases, such as tuberculosis,
malaria, hepatitis C, filariasis, leishmaniasis, and schistosomia-
sis (Boussiotis et al., 2000; Carvalho et al., 1994; King et al.,
1996; MacDonald et al., 2002; Mahanty et al., 1997; Plebanski366 Immunity 29, September 19, 2008 ª2008 Elsevier Inc.et al., 1999). Themost remarkable example of this control is illus-
trated by its crucial role during acute infection of mice with Toxo-
plasma gondii. In this model, IL-10 production by T cells is the
key regulator of effector cell responses, because IL-10-deficient
mice can control parasite number, but they succumb to lethal im-
munopathology driven by unrestrained effector cell responses
(Gazzinelli et al., 1996). During Th2 cell-dominated helminths in-
fection, the majority of IL-10 is produced by the Th2 cells (Moore
et al., 2001). Besides T cells, IL-10 can also be produced by
numerous cell types, including B cells, natural killer (NK) cells,
macrophages, and DCs (reviewed inMoore et al., 2001). In acute
Plasmodium yoelii infection, a subset of regulatory DCs express-
ing CD11cloCD45RBhi and inducing IL-10-secreting T cells
becomes the predominant DC population in the spleen (Wong
and Rodriguez, 2008). IL-10 can also be produced by natural
Treg cells and, in some cases, is associated with their function;
however, in most cases, the inducible Tr1 cell population is the
relevant source of this cytokine during infection. During various
infections, Tr1 cells develop from conventional T cells after en-
countering with certain signals, such as exposure to deactivated
or immature APCs, repeated exposure to antigen, or IL-10 itself
(reviewed in O’Garra et al., 2004; Roncarolo et al., 2006). Of note,
these conditions prevail during chronic infection in which APC
functions are often targeted by the pathogen and cells of the im-
mune system are chronically exposed to microbial antigens.
Consistent with a role for these cells in human disease, Tr1 cell
clones can be isolated from patients who are chronically infected
with hepatitis C virus (HCV) (MacDonald et al., 2002). Interest-
ingly, these regulatory clones had similar viral antigen specificity
to protective Th1 cell clones isolated from the same patient
(MacDonald et al., 2002). Definedmicrobial products canmanip-
ulate DCs in a way that induces Treg cell populations (Mills and
McGuirk, 2004) (Figure 1). For example, filamentous haemagglu-
tinin (FHA) from Bordetella pertussis was shown to induce IL-10
production by DCs; these DCs favor the differentiation of naive
T cells into Tr1 cells (McGuirk et al., 2002). Similarly, Tr1 cells
can be generated from naive T cells in the presence of DCs stim-
ulated with phosphatidylserine from Schistosoma mansoni (Van
der Kleij et al., 2002).
One promising therapeutic approach has emerged from the
observation that microbial products can favor the induction of
Tr1 cell populations in vivo. Exposure of mice to S. mansoni an-
tigen prevents development of type 1 diabetes in NOD mice
(Zaccone et al., 2003), as well as experimental colitis (Elliott
et al., 2003). The use of singlemicrobial molecules as therapeutic
agents has been recently shown as FHA of Bordetella pertussi
can efficiently treat experimental colitis (Braat et al., 2006).
Although Tr1 cells define a population of T cells that can pro-
duce IL-10 and/or TGF-b, some IL-10-producing T cells can also
produce IFN-g. The autocrine regulation by IL-10 of Th1 and Th2
cells was initially described in human clones (Del Prete et al.,
1993). In the context of an infectious disease, IFN-g and IL-10
double producers were first described in the bronchoalveolar la-
vage of patients with tuberculosis (Gerosa et al., 1999) and in in-
dividuals chronically infected with Borrelia burgdorferi (Pohl-
Koppe et al., 1998). Indeed, in many chronic infections, in
humans and experimental animals, the presence of CD4+
T cells that produce high amounts of both IL-10 and IFN-g
have been documented (reviewed in Trinchieri, 2001).
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T cells emerge during experimental infection with T. gondii and in
amodel of nonhealing Leishmaniasis (Anderson et al., 2007; Jan-
kovic et al., 2007) and that these cells share many features with
Th1 cells and were the main source of protective IL-10. These
T cells were identified as activated T-bet+ Th1 cells andwere dis-
tinct from Th2 cells, natural Treg cells, or other subsets of induc-
ible regulatory T cells. Unlike IFN-g production, IL-10 production
was transient, observed in only a fraction of the IFN-g-producing
cells, and was produced more rapidly by recently activated
T cells than by resting T cells (Jankovic et al., 2007). The instabil-
ity of IL-10 synthesis, which was observed only when the Th1
cells were fully activated, is probably necessary to prevent sus-
tained suppression of effector functions. Thus, it appears that, in
some cases, cells with regulatory properties could arise from
fully differentiated Th1 cells as a negative-feedback loop. It is
likely that numerous previous studies of Tr1 cells were in fact
incriminating similar populations. These IFN-g- and IL-10-pro-
ducing T cells may represent a dominant regulatory response
to infections that induce highly polarized Th1 cell responses.
The nature of the APC or status of activation required for the
imprinting of IL-10 on these Th1 cells remains poorly understood,
but some evidence suggests that the cytokines produced by
DCs could contribute to this phenotype. For instance, repetitive
exposure to IL-12 could induce IL-10 on IFN-g-producing cells
(Meyaard et al., 1996). Several recent reports suggested that
IL-27 might be an important determinant for the induction of
IL-10 on Th1 cells (Awasthi et al., 2007; Fitzgerald et al., 2007;
Stumhofer et al., 2007). A role for this cytokine as a regulatory
mediator has recently emerged. IL-27 can limit Th1, Th2, and
Th17 cell responses in various models of infection and autoim-
munity (Kastelein et al., 2007). DCs from the spleen modified
by exposure to TGF-b-producing Treg cells acquire a plasmacy-
toid phenotype and release TGF-b and IL-27, which in turn allow
the induction of IL-10-producing T cells (Awasthi et al., 2007).
How IL-27 could contribute to the induction of IL-10 in the GI
tract and how this pathway could contribute to the maintenance
of gut homeostasis remains to be addressed.
Induction of Foxp3+ Treg Cells by DCs during Infections
Acute infection with Listeria monocytogenes in mice failed to in-
duce Foxp3 by conventional CD4+ T cells (Fontenot et al.,
2005b). Thus, highly inflammatory environments that will prevail
in acute infection may not favor the emergence of Foxp3+ T cells.
This hypothesis is supported by the observation that Th1 or Th2
cell-polarizing cytokines can interfere with the induction of these
cells (Wei et al., 2007). However, chronic infections may require
an additional layer of regulation, which would be provided by
converted Foxp3+ Treg cells. This hypothesis is supported by
the observation that during infection, the downstream effects
of inflammatory responses are also often associated with anti-
inflammatory processes, including TGF-b production. Further-
more, some pathogens target sites in which TGF-b is highly
produced, such as the GI tract, the skin, and the eye, which
may assist in the conversion in vivo. TGF-b can be also produced
by infected cells or by cells the microorganisms are in contact
with, or arise as a result of an inflammatory process. For exam-
ple, the trypomastigote stage of Trypanosoma cruzi induced
TGF-b and IL-10 secretion by DCs (Poncini et al., 2008). Compel-ling data in a mouse model of malaria suggest that TGF-b and
Treg cells are central regulators of immunopathology and para-
site expansion (Walther et al., 2005). During late infection with
Plasmodium yoelii infection, DCs migrate to the spleen of in-
fected mice and secrete TGF-b together with IL-10 and PGE2
(Ocana-Morgner et al., 2007). After experimental malaria infec-
tion of human volunteers, enhanced TGF-b and Foxp3+ Treg
cell responses in peripheral bloodmononucleated cells correlate
with a faster parasitic growth rate (Walther et al., 2005). Cells with
natural Treg cell characteristics are rapidly induced after blood-
stage infection and are associated with a decrease of proinflam-
matory cytokines and antigen-specific responses. Monocytes
are a likely source of the early TGF-b production in this infection
(Walther et al., 2005). Some nematodes can themselves express
homologs of TGF-b (Gomez-Escobar et al., 1997). Compelling
experimental data support the idea that Foxp3+ Treg cells can
be induced during Heligmosomoides polygyrus infection (Finney
et al., 2007). This pathway may not be limited to the GI tract,
because we found that the Bacillus Calmette-Guerin (BCG) can
induce new populations of Foxp3+ T cells in vivo that accumulate
at the dermal site of infection (Y.B., unpublished data). The
relative contribution of these converted Treg cells to peripheral
tolerance and the outcome of infections, as well as how patho-
gens can utilize or interfere with this pathway to favor their own
survival, remains to be addressed. Currently, in absence of de-
finitive markers to distinguish endogenous versus converted
Foxp3+ regulatory T cells, these questions will remain difficult
to answer.
However, the interaction with persistent microbes does not al-
ways lead to the induction of Treg cells. As discussed above, ac-
tivation of DCs that can bemediated by TLR ligands impairs Treg
conversion. We found that gut flora-derived DNA (gfDNA), but
not other TLR agonists, strongly constrained the capacity of lam-
ina propria dendritic cells to induce Treg cell conversion in vitro
and can act as a natural adjuvant for priming intestinal responses
via modulation of Treg-Teff (T effector) cell equilibrium (Y.B.,
unpublished data). This would suggest that in some highly regu-
lated environment, persistent microbes might limit peripheral
conversion by modulating APC function.
DCs as Targets of Treg Cell Regulation: The Concept
of Infectious Tolerance
Treg cells directly interact with DCs in vivo (Tang et al., 2006).
Treg cells, which are more mobile than naive T cells in vitro,
out compete the latter in aggregating around DCs via a mecha-
nism dependent on LFA-1 (Onishi et al., 2008). After forming ag-
gregates, Treg cells specifically downregulate the expression of
CD80 and CD86, but not CD40 or class II MHC, on DCs in both
a CTLA-4- and LFA-1-dependent manner (Onishi et al., 2008).
Treg cells exert this CD80- and CD86-downmodulating effect
even in the presence of strong DC-maturating stimuli. A conse-
quence of this interaction is the induction of infectious tolerance,
which is believed to allow the expansion of the regulatory envi-
ronment in a bystander manner. The interaction of Treg cells
with DCs impairs the capacity of the antigen-presenting cell to
establish lasting interaction with effector T cells (Tadokoro
et al., 2006), and CTLA-4 appears to play an important role in
this process (Oderup et al., 2006). Importantly, Treg cells via
CTLA-4 interaction can initiate the immunoregulatory pathwayImmunity 29, September 19, 2008 ª2008 Elsevier Inc. 367
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indoleamine 2,3-dioxygenase (IDO) downregulates immune
responses are still elusive and may involve multiple pathways.
In particular, CD4+ T cells exposed to low tryptophan and kynur-
enin produced increased amounts of IL-10 and TGF-b but little
IFN-g and IL-4 (Fallarino et al., 2006).
In a model of Aspergillus conidia infection in mice, control of
allergic immunopathology induced by the fungus requires the
sequential activity of various populations of Treg cells (Montag-
noli et al., 2006). Early in infection, inflammation is controlled by
the expansion and local recruitment of natural Treg cells that are
capable of limiting innate immune responses through the com-
bined action of IL-10 and CTLA-4 to induce the production of
IDO by APCs. This control of innate responses, in particular of
DCs, leads to the subsequent activation and expansion of Tr1
cells that produce both IL-10 and TGF-b. In turn, Tr1 cells can
inhibit Th2 cells, which are responsible for the allergic response
to the fungus (Montagnoli et al., 2006). This sequential role for
various populations of regulatory T cells orchestrated by DCs
may not be an exception but the rule, asmost infections proceed
through various stages and therefore require various layers of
regulation.
Immune regulation has to be shaped in a manner specific to
themicroenvironment targeted. Because a large number of stud-
ies evaluating the mechanism of Treg cell induction were done
with mitogenic stimuli or DCs from lymphoid organs, our under-
standing of tissue-specific DCs, the complexity of the local sub-
sets, and the peculiarity of their function remains sparse and
clearly requires further exploration. An additional challenge to
a better understanding of local regulation is associated with
the extreme plasticity of both DC and Treg cell populations. Ev-
idence suggests that Treg cells may not always be stable and
that some interactions with some stimulatory signals can depro-
gram them (Degauque et al., 2008). Furthermore, even regulatory
DCs conditioned by a specific microenvironment can become
potent inducers of immune responses upon inflammatory set-
tings. We have only just begun to grasp the complexity of the di-
alog between tissue-specific DCs and regulatory T cells, and
a better understanding of this local regulation is clearly needed
for the design of rational and targeted approaches to either
disturb (as in the case of tumors) or restore local homeostasis
(as in the case of gut inflammatory diseases).
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